Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination
- PMID: 18235144
- PMCID: PMC2390945
- DOI: 10.2215/CJN.02010507
Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination
Abstract
Background and objectives: Inflammation-induced atherosclerosis and enhanced susceptibility to infection are linked to immune dysfunction and account for an important part of mortality in hemodialysis patients. This 4-yr prospective study aimed to use cytokine proteomic determination for predicting cardiovascular and noncardiovascular mortality in hemodialysis patients.
Design, setting, participants, & measurements: Levels of 12 cytokines were measured using a proteomic biochip system in 134 patients who were on stable hemodialysis and compared with a control group of 150 healthy volunteers. Cox proportional hazards regression analysis was used to determine the relationship between cytokine and clinical outcome.
Results: A proinflammatory state characterized by decreased anti-/proinflammatory cytokine ratio was evidenced in hemodialysis patients compared with control subjects. After adjustment for age, gender, smoking, and high-sensitivity C-reactive protein levels, IL-6 and (IL-4+IL-10)/IL-6 ratio were associated with a significant and specific enhanced hazard ratio of cardiovascular mortality (hazard ratio 11.32 [95% confidence interval 2.52 to 50.90; P < 0.01] and hazard ratio 3.14 [95% confidence interval 1.20 to 8.22; P < 0.05], respectively, when comparing the third and first tertiles). It is interesting that (IL-4+IL-6+IL-10)/(IL-2+IFN-gamma) ratio, used as a marker of lymphocytes T helper subsets cytokine secretion, was associated only with noncardiovascular mortality (hazard ratio 4.93; 95% confidence interval 1.03 to 23.65; P < 0.05).
Conclusion: Beyond the strong prediction of cardiovascular mortality by IL-6, determination of cytokine ratios can be useful to identify hemodialysis patients with increased noncardiovascular mortality risk.
Similar articles
-
Serum β-trace protein and risk of mortality in incident hemodialysis patients.Clin J Am Soc Nephrol. 2012 Sep;7(9):1435-45. doi: 10.2215/CJN.02240312. Epub 2012 Jun 28. Clin J Am Soc Nephrol. 2012. PMID: 22745274 Free PMC article.
-
Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.Kidney Int. 2018 Jan;93(1):221-230. doi: 10.1016/j.kint.2017.07.010. Epub 2017 Sep 21. Kidney Int. 2018. PMID: 28941940
-
Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.Am J Kidney Dis. 2014 Dec;64(6):954-61. doi: 10.1053/j.ajkd.2014.07.010. Epub 2014 Sep 27. Am J Kidney Dis. 2014. PMID: 25266479 Free PMC article.
-
Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1265-1273. doi: 10.2215/CJN.10881016. Epub 2017 May 11. Clin J Am Soc Nephrol. 2017. PMID: 28495863 Free PMC article.
-
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.J Nephrol. 2019 Feb;32(1):111-119. doi: 10.1007/s40620-018-0556-5. Epub 2018 Nov 29. J Nephrol. 2019. PMID: 30499038 Free PMC article.
Cited by
-
A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study.BMC Cancer. 2012 Sep 7;12:393. doi: 10.1186/1471-2407-12-393. BMC Cancer. 2012. PMID: 22954206 Free PMC article.
-
T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.Front Med (Lausanne). 2021 Sep 9;8:742419. doi: 10.3389/fmed.2021.742419. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34568395 Free PMC article.
-
Proteomic Investigations into Hemodialysis Therapy.Int J Mol Sci. 2015 Dec 10;16(12):29508-21. doi: 10.3390/ijms161226189. Int J Mol Sci. 2015. PMID: 26690416 Free PMC article. Review.
-
Inflammation as a target for improving health in chronic kidney disease.F1000 Med Rep. 2010 Dec 17;2:88. doi: 10.3410/M2-88. F1000 Med Rep. 2010. PMID: 21283598 Free PMC article.
-
What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?Front Med (Lausanne). 2023 Nov 15;10:1268748. doi: 10.3389/fmed.2023.1268748. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034546 Free PMC article. Review.
References
-
- Pupim LB, Himmelfarb J, McMonagle E, Shyr Y, Ikizler TA: Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 65: 2371–2379, 2004 - PubMed
-
- Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 138: S419–S420, 1999 - PubMed
-
- Diaz MN, Frei B, Vita JA, Keaney JF Jr: Antioxidants and atherosclerotic heart disease. N Engl J Med 337: 408–416, 1997 - PubMed
-
- Drueke TB, Khoa TN, Massy ZA, Witko-Sarsat V, Lacour B, Descamps-Latscha B: Role of oxidized low-density lipoprotein in the atherosclerosis of uremia. Kidney Int Suppl 78: S114–S119, 2001 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials